A St. Johnsville woman is suing medical manufacturer McNeil Consumer Health Care over a bottle of Tylenol.
Lori Quackenbush alleged in her complaint the pills were “contaminated with a foreign substance, bacteria or other agent prone to cause human sickness,” that caused her health problems worth up to $75,000 in damages.
She purchased the bottle of Tylenol Arthritis Pain Caplets at Kinney Drugs in November 2009.
The pills were manufactured by McNeil Consumer Healthcare, a Pennsylvania subdivision of New Jersey based Johnson & Johnson.
Upon taking the medication, she “became extremely ill, sick and otherwise injured,” according to her complaint, and had to seek medical attention. Johnson & Johnson officials did not respond to inquiries Thursday, but a section of the Tylenol website is dedicated to product recall information.
“In November 2009, five lots of this product,” is said of Tylenol Arthritis Pain Caplets, “were recalled due to consumer reports of an unusual moldy, musty, or mildew-like odor that was associated with nausea, stomach pain, vomiting and diarrhea.”
Quackenbush could not be reached for comment on what lot number her bottle came from, but her attorney Robert Abdella said it was likely part of that recall.
“There was a batch that was later recognized by Johnson & Johnson to be defective,” he said, adding that his client ingested the Tylenol before the recall was announced.
“She certainly didn’t know it was contaminated,” he said.
While Johnson & Johnson did eventually recall the product, the complaint says they “negligently and carelessly failed to warn the public and the plaintiff in particular of the dangers inherent is ingesting said product.”
It has been nearly three years since the actual event, but Abdella said his client spent that time trying unsuccessfully to settle her claim out of court.
He couldn’t comment on what health problems exactly the Tylenol caused, saying Quackenbush felt it was a personal matter, but said she still feels the effects of the allegedly contaminated pills.
It is currently unclear how much Quackenbush will actually seek in damages, though it will be less than $75,000 since that is the threshold that would bring the suit into Federal Court.
“We’ll see when we get all the medical evidence together,” Abdella said.